Lucy Lim
Impact in
-
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
-
- Hepatitis C virus research 3
- Hepatocellular Carcinoma Treatment and Prognosis 1
-
- Hepatitis B Virus Studies 3
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Peter Angus (5 shared papers)Amanda Nicoll (5 shared papers)Hemant Shah (1 shared paper)Christine Cserti‐Gazdewich (1 shared paper)Henning Grønbæk (2 shared papers)Gerda Elisabeth Villadsen (2 shared papers)Ian Kronborg (2 shared papers)Danny Liew (2 shared papers)
In The Last Decade
Lucy Lim
7 papers receiving 118 citations
Peers
Comparison fields: 5 of 45
- Hepatology 45
- Epidemiology 42
- Oncology 32
- Immunology 23
- Cancer Research 15
Countries citing papers authored by Lucy Lim
This map shows the geographic impact of Lucy Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy Lim more than expected).
Fields of papers citing papers by Lucy Lim
This network shows the impact of papers produced by Lucy Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy Lim. The network helps show where Lucy Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Lucy Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 30 | |
| 2 | 2014 | 22 | |
| 3 | 2011 | 20 | |
| 4 | 2015 | 20 | |
| 5 | 2015 | 19 | |
| 6 | 2016 | 8 | |
| 7 | Tenofovir Rescue Therapy Achieves Long-Term Suppression of HBV Replication in Patients with Multi-Drug Resistant HBV: 4 Year Follow-Up of the TDF109 Cohort | 2012 | 3 |
About Lucy Lim
Lucy Lim is a scholar working on Hepatology, Epidemiology, Surgery, Immunology and Infectious Diseases, having authored 7 papers that have together received 122 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Pancreatic function and diabetes (1 paper), Signaling Pathways in Disease (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Hepatology (45 citations), Epidemiology (42 citations), Oncology (32 citations), Immunology (23 citations) and Cancer Research (15 citations). Lucy Lim has collaborated with scholars based in Australia, Denmark and Canada. Frequent co-authors include Peter Angus, Amanda Nicoll, Hemant Shah, Christine Cserti‐Gazdewich, Henning Grønbæk, Gerda Elisabeth Villadsen, Ian Kronborg, Danny Liew, Alexandra Gorelik and Jan Frystyk. Their work appears in journals such as Journal of Gastroenterology and Hepatology, Journal of Pharmacy Practice and Research, Liver International, Scandinavian Journal of Clinical and Laboratory Investigation and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.